Millrace Asset Group’s Edwards Lifesciences EW Stock Holding History

Millrace Asset Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-54,000	Closed	-$1.69M	–	59
2016 Q4	$1.69M	Buy	+54,000	New	+$1.75M	1.84%	21
2016 Q2	–	Sell	-63,000	Closed	-$1.85M	–	51
2016 Q1	$1.85M	Buy	+63,000	New	+$1.74M	2.55%	16
2015 Q2	–	Sell	-17,058	Closed	-$405K	–	57
2015 Q1	$405K	Sell	17,058 -30,618	-64%	-$687K	0.45%	50
2014 Q4	$1.01M	Buy	+47,676	New	+$958K	1.05%	46

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millrace Asset Group's EW Position: Q1 2017 in Review

Millrace Asset Group sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 54,000 shares — an estimated $1.69M sold.

Millrace Asset Group first reported a position in EW in Q4 2014 and held it in 4 quarters. The position peaked at $1.85M in Q1 2016. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

Millrace Asset Group reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
Millrace Asset Group sold 54,000 Edwards Lifesciences shares in Q1 2017, an estimated $1.69M.
Millrace Asset Group first reported a position in Edwards Lifesciences in Q4 2014 and held it in 4 quarters.
Millrace Asset Group's Edwards Lifesciences position peaked at $1.85M in Q1 2016.
691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Millrace Asset Group's 13F filing for Q1 2017, filed 9 May 2017.